H2AX and cancer: Genome-wide siRNA and CRISPR screenings in cancer cells further validated that knockdown/knockout of spliceosomal genes disrupts DNA repair processes42–45, resulting in increased levels of H2AX phosphorylation96, and synthetic lethality for cancer cells in combination with DNA-damaging agents95.